Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis.

Glaivy BatsuliKaren L ZimowskiKelly TickleShannon L MeeksRobert F Sidonio

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2019)

Immune tolerance induction while on emicizumab prophylaxis is a feasible approach in paediatric haemophilia A patients with inhibitors. This is the first report of the concomitant use of ITI in patients receiving emicizumab prophylaxis described as the 'Atlanta Protocol'.

Keyphrases

intensive care unit
emergency department
randomized controlled trial